Current Events

The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The 2023 R&I meeting will focus on cutting edge innovation, comprising the following four main sessions:
1 - Synthetic biology
2 - Healthy ageing
3 - AI driven drug discovery
4 - Ultra-rare disease drug discovery and personalized therapies
<< less

The 2023 ELRIG Research & Innovation conference will discuss how emerging biology and cutting-edge technologies are pioneering the medicines of tomorrow. Bringing together scientists, researchers and entrepreneurs with bold ideas to serve our shared ambitions in creating the next generation of therapeutics to cure more patients around the world. The more >>

Welcome to the SBNS Spring meeting 2023
29th - 31st March

The British Association for Slavonic and East European Studies (BASEES) invites proposals for panels and roundtables, and papers for its 2023 annual conference. BASEES 2023 is being held from the 31^st of March to the 2^nd of April and will be hosted at the University of Glasgow, United Kingdom. The last conference welcomed over 400 delegates from over 30 countries around the world. 

BASEES welcomes paper, panel and roundtable proposals in the following areas: Politics; History; Sociology and Geography; Film and Media, Languages and Linguistics; Literatures and Cultures; and Economics. The conference especially welcomes participation by postgraduate research students and early career scholars. .

<< less

The British Association for Slavonic and East European Studies (BASEES) invites proposals for panels and roundtables, and papers for its 2023 annual conference. BASEES 2023 is being held from the 31^st of March to the 2^nd of April and will be hosted at the University of Glasgow, United Kingdom. The last conference welcomed over more >>

The 2023 British Society for Parasitology Spring Meeting will be held at the University of Edinburgh, in partnership with the British Ecological Society (BES). Edinburgh boasts a long association with protist parasitology (not least in training David Bruce!) and also benefits from strong links to ecology, both of which will be represented by distinct streams and keynote lectures. As well as welcoming all general parasitology themes across the discipline, there will be sessions dedicated to host-pathogen interactions, wild immunology, immunoparasitology, veterinary parasitology, and therapies and diagnostics. Confirmed speakers include Judi Allen, Robin Allshire, Simon Babayan, Jake Baum, Emma Cunningham, Simon Draper, Vanessa Ezenwa, De’Broski Herbert, Neil Mabbott, Iris Mair, Maria Mota, Monica Mugnier, Gérald Spaeth, Charles Wondji and Alena Zíková. << less

The 2023 British Society for Parasitology Spring Meeting will be held at the University of Edinburgh, in partnership with the British Ecological Society (BES). Edinburgh boasts a long association with protist parasitology (not least in training David Bruce!) and also benefits from strong links to ecology, both of which will be represented by distinct more >>

Sustainability, or the approaches to reduce the impact our work and daily lives have on the environment, has rightfully been a topic of much discussion. The problematic accumulation of plastic waste and the rise in energy costs emphasises the need to put sustainability high on the agenda for every organisation. Join us for our Networking Event, with talks from Life Sciences Sustainability professionals where we will discuss and share sustainability practices within Drug Discovery research labs.
<< less

Sustainability, or the approaches to reduce the impact our work and daily lives have on the environment, has rightfully been a topic of much discussion. The problematic accumulation of plastic waste and the rise in energy costs emphasises the need to put sustainability high on the agenda for every organisation. Join us for our Networking Event, with more >>

Scotland has a proud history of innovation and drug discovery the likes of which are still being felt worldwide. Fleming's penicillin and Isaac’s interferon being but two examples. With over 150 pharma services/ supply companies and 19 universities Scotland is one of the most advanced life science sectors in the UK and the entire world. So come and here how Scotland is continuing to innovate and shape drug discovery, using a plethora approach from traditional small molecules to therapeutics proteins, biologics and cells, vaccines, RNA and AI approaches. << less

Scotland has a proud history of innovation and drug discovery the likes of which are still being felt worldwide. Fleming's penicillin and Isaac’s interferon being but two examples. With over 150 pharma services/ supply companies and 19 universities Scotland is one of the most advanced life science sectors in the UK and the entire world. So come and more >>

The inaugural ELRIG meeting on Therapeutic OLIGOs combined with the 8th European Chemical Biology Symposium (ECBS) will be held on May 9-11 at the beautiful AstraZeneca R&D site in Gothenburg. This interactive 3-day event will host leading scientists from academia, industry and the vendor community to discuss recent advancements in the discovery of therapeutic OLIGOs and in the Chemical Biology research field in Europe and internationally. The ECBS part of the meeting is co-organized by EU-OPENSCREEN and the EuChemS Division of Chemistry in Life Sciences, and includes contributions from key academic chemical biology research groups in Europe. Our ambition is to create an open access meeting and an inspiring environment for networking between biologists and chemists to fuel cross-fertilisation between research areas.
OLIGOs such as ASOs, siRNAs and other mRNA-targeted therapeutics are impacting patients daily. To further expand the scope of these drug modalities the field is exploring new ways to formulate and distribute the cargo to improve the reach of additional disease-relevant tissue. Efforts include various ways of targeting the delivery, for example by conjugating the cargo to functional groups that interact with specific cell types. This is one area in which developments interplay with the field of chemical biology, where the aim is to exploit chemistry for the purpose of understanding and manipulating biology. With the recent announcement of the latest Nobel Prize in Chemistry for bio-orthogonal chemistry and click chemistry, there is more reason than ever to discuss the next advancements that will impact our understanding of and man-made changes to biology. This meeting will explore these opportunities and challenges in six focus areas as outlined below:
Therapeutic OLIGO profiling
The starting session will focus on the biological profiling of treatment response to oligonucleotides and the underlying characterisation of cellular model systems to achieve this in a rational manner. This includes the application of different techniques for understanding molecular mechanisms behind mRNA modulation and changes to their levels using e.g. RNA sequencing approaches to understand safety aspects. We will also explore novel developments in spatially resolved biology to understand the sequence of events from endosomal uptake, release and delivery to site of action.
Advancements in OLIGO design and synthesis
Short modified oligonucleotides such as ASOs are successfully used as gene-targeted drugs, developments that were made possible by chemistry advancements to improve in vivo stability and specificity, while reducing toxicity. There is currently a strong focus on improving productive uptake in physiologically relevant tissue, where the chemical matter is at interplay with the packaging of the cargo in novel formulations.
Novel formulations and biomarker analysis
Delivery of therapeutic OLIGOs to the intended target tissue is critically important for expanding their clinical utilities. Targeted delivery can be achieved by incorporation of functional groups with the cargo, or alternatively through functionalization of the carrier moieties such as nanoparticles. Understanding successful delivery is intimately linked to the availability of suitable biomarkers of response, the relationships of which will be explored in this session.
Chemical probe-induced protein interaction and degradation
The available toolbox of chemical probes and drugs has recently expanded to include a plethora of approaches for achieving targeted protein degradation. The fundamental science driving this exciting new field is the generation of molecules capable of modulating or engineering new protein-protein interactions, which subsequently exploit the ubiquitin-proteasomal system or other protein degradation pathways. In this session we will explore technologies that are critical for in-depth studies of these interactions.
New ways to shape and interrogate biology through chemistry
The concept of using chemistry to interrogate biology is fundamental to the chemical biology community. We are now going beyond this goal, with efforts to create new biology, for example by the introduction of non-naturally occurring building blocks. In this session we will explore this line of thinking and potential future applications.
Innovative tools and methods for advanced cell profiling
The future of life science research sits with our ability to fully embrace big data, which is increasingly used for better understanding treatment responses but also for better characterising cellular model systems. Here we will explore the future of compound-induced fingerprinting, where details on the model system become an integral part of this interpretation.
<< less

The inaugural ELRIG meeting on Therapeutic OLIGOs combined with the 8th European Chemical Biology Symposium (ECBS) will be held on May 9-11 at the beautiful AstraZeneca R&D site in Gothenburg. This interactive 3-day event will host leading scientists from academia, industry and the vendor community to discuss recent advancements in the discovery of more >>

Leading 2nd International conference on Cancer Science and Therapy: Cancer 2023 provides a great platform for experts, scientists, researchers and students to give oral/poster and video presentations and get global exposure to your research in Tokyo, Japan from May 15-16, 2023. Take a glance at the scientific sessions to see the research areas covered in Cancer Conference 2023 to meet experts across the globe. Explore Tokyo for 2 days with your friends and family!
For more info, please visit: https://www.cancer.scientexconference.com/
<< less

Leading 2nd International conference on Cancer Science and Therapy: Cancer 2023 provides a great platform for experts, scientists, researchers and students to give oral/poster and video presentations and get global exposure to your research in Tokyo, Japan from May 15-16, 2023. Take a glance at the scientific sessions to see the research areas covered more >>

Scientex conferences cordially invite all the researchers, scientists, academia, and students across the world to engage in our Hybrid Event “International Conference on Neuroscience and Neurology” scheduled during May 25-26,2023 in Tokyo, Japan which includes prompt keynote presentations, oral talks, poster presentations, seminars, workshops, and exhibitions.

Neuroscience Congress 2023 will also host a webinar on June 01-02, 2023 at (GMT+9).

The theme of the conference: Preliminary Research Colloquium of Neuroscience and Neurology of future advancement. << less

Scientex conferences cordially invite all the researchers, scientists, academia, and students across the world to engage in our Hybrid Event “International Conference on Neuroscience and Neurology” scheduled during May 25-26,2023 in Tokyo, Japan which includes prompt keynote presentations, oral talks, poster presentations, seminars, workshops, and more >>

Drug delivery systems for the next generation of therapeutics
Although small molecule therapeutics still account for 90% of approved medicines, patient expectations are increasingly driving the industry towards targeted, precision treatments and new therapeutic modalities, which often require sophisticated delivery technologies to be effective medicines.
ELRIG are partnering with the European Technology Platform on Nanomedicine (ETPN), British Society for Nanomedicine and the University of Liverpool at Nanomed Europe #NME23.
With representatives from big pharma and biotech the ELRIG session will concentrate on the challenges of R&D in nanomedicines from an industry perspective. Covering a range of modalities, it will explore how drug dendrimer conjugates can improve the properties of small molecule therapeutics, discuss developing a lipid nanoparticle drug delivery platform for distinct diseases and report progress in the targeted delivery of exosomes.
<< less

Drug delivery systems for the next generation of therapeutics
Although small molecule therapeutics still account for 90% of approved medicines, patient expectations are increasingly driving more >>

Spanning multiple therapeutic areas from regenerative medicine to immunotherapy, the simplistic approach of repurposing patients’ autologous cells has been a groundbreaking therapeutic approach greatly expanding the horizon of potential medicines. Join us on the 15th of September, 2023, to learn the newest advancements in cell & gene therapy and network with pioneering scientist from academia, pharma and biotech in Switzerland. << less

Spanning multiple therapeutic areas from regenerative medicine to immunotherapy, the simplistic approach of repurposing patients’ autologous cells has been a groundbreaking therapeutic approach greatly expanding the horizon of potential medicines. Join us on the 15th of September, 2023, to learn the newest advancements in cell & gene therapy and network more >>